The global Gene Therapy in Oncology market size was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 12.34 billion by 2030, at a CAGR of 23.6% during the forecast period 2024-2030.
United States Gene Therapy in Oncology market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 3.87 billion by 2030, at a CAGR of 22.9% during the forecast period 2024-2030.
Therapeutic approach using genetic material to treat or prevent cancer.
Rapid growth driven by advancements in gene editing technologies and delivery methods. Increasing investment in cancer research and personalized medicine. Ongoing clinical trials for various cancer types showing promising results.
Report Overview
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
This report provides a deep insight into the global Gene Therapy in Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy in Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy in Oncology market in any manner.
Global Gene Therapy in Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology
Market Segmentation (by Type)
Ex Vivo
In Vivo
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy in Oncology Market
Overview of the regional outlook of the Gene Therapy in Oncology Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy in Oncology
1.2 Key Market Segments
1.2.1 Gene Therapy in Oncology Segment by Type
1.2.2 Gene Therapy in Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy in Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy in Oncology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy in Oncology Market Competitive Landscape
3.1 Global Gene Therapy in Oncology Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy in Oncology Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy in Oncology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy in Oncology Sales Sites, Area Served, Product Type
3.6 Gene Therapy in Oncology Market Competitive Situation and Trends
3.6.1 Gene Therapy in Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy in Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy in Oncology Industry Chain Analysis
4.1 Gene Therapy in Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy in Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy in Oncology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy in Oncology Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy in Oncology Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy in Oncology Price by Type (2019-2024)
7 Gene Therapy in Oncology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy in Oncology Market Sales by Application (2019-2024)
7.3 Global Gene Therapy in Oncology Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy in Oncology Sales Growth Rate by Application (2019-2024)
8 Gene Therapy in Oncology Market Segmentation by Region
8.1 Global Gene Therapy in Oncology Sales by Region
8.1.1 Global Gene Therapy in Oncology Sales by Region
8.1.2 Global Gene Therapy in Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy in Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy in Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy in Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy in Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy in Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Gene Therapy in Oncology Basic Information
9.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Overview
9.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Gene Therapy in Oncology SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Cold Genesys
9.2.1 Cold Genesys Gene Therapy in Oncology Basic Information
9.2.2 Cold Genesys Gene Therapy in Oncology Product Overview
9.2.3 Cold Genesys Gene Therapy in Oncology Product Market Performance
9.2.4 Cold Genesys Business Overview
9.2.5 Cold Genesys Gene Therapy in Oncology SWOT Analysis
9.2.6 Cold Genesys Recent Developments
9.3 Advantagene
9.3.1 Advantagene Gene Therapy in Oncology Basic Information
9.3.2 Advantagene Gene Therapy in Oncology Product Overview
9.3.3 Advantagene Gene Therapy in Oncology Product Market Performance
9.3.4 Advantagene Gene Therapy in Oncology SWOT Analysis
9.3.5 Advantagene Business Overview
9.3.6 Advantagene Recent Developments
9.4 Amgen
9.4.1 Amgen Gene Therapy in Oncology Basic Information
9.4.2 Amgen Gene Therapy in Oncology Product Overview
9.4.3 Amgen Gene Therapy in Oncology Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Gene Therapy in Oncology Basic Information
9.5.2 AstraZeneca Gene Therapy in Oncology Product Overview
9.5.3 AstraZeneca Gene Therapy in Oncology Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Bio-Path Holdings
9.6.1 Bio-Path Holdings Gene Therapy in Oncology Basic Information
9.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Overview
9.6.3 Bio-Path Holdings Gene Therapy in Oncology Product Market Performance
9.6.4 Bio-Path Holdings Business Overview
9.6.5 Bio-Path Holdings Recent Developments
9.7 CRISPR Therapeutics
9.7.1 CRISPR Therapeutics Gene Therapy in Oncology Basic Information
9.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Overview
9.7.3 CRISPR Therapeutics Gene Therapy in Oncology Product Market Performance
9.7.4 CRISPR Therapeutics Business Overview
9.7.5 CRISPR Therapeutics Recent Developments
9.8 Editas Medicine
9.8.1 Editas Medicine Gene Therapy in Oncology Basic Information
9.8.2 Editas Medicine Gene Therapy in Oncology Product Overview
9.8.3 Editas Medicine Gene Therapy in Oncology Product Market Performance
9.8.4 Editas Medicine Business Overview
9.8.5 Editas Medicine Recent Developments
9.9 Geron Corp
9.9.1 Geron Corp Gene Therapy in Oncology Basic Information
9.9.2 Geron Corp Gene Therapy in Oncology Product Overview
9.9.3 Geron Corp Gene Therapy in Oncology Product Market Performance
9.9.4 Geron Corp Business Overview
9.9.5 Geron Corp Recent Developments
9.10 Idera Pharmaceuticals
9.10.1 Idera Pharmaceuticals Gene Therapy in Oncology Basic Information
9.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Overview
9.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Product Market Performance
9.10.4 Idera Pharmaceuticals Business Overview
9.10.5 Idera Pharmaceuticals Recent Developments
9.11 Intellia Therapeutics
9.11.1 Intellia Therapeutics Gene Therapy in Oncology Basic Information
9.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Overview
9.11.3 Intellia Therapeutics Gene Therapy in Oncology Product Market Performance
9.11.4 Intellia Therapeutics Business Overview
9.11.5 Intellia Therapeutics Recent Developments
9.12 Johnson and Johnson
9.12.1 Johnson and Johnson Gene Therapy in Oncology Basic Information
9.12.2 Johnson and Johnson Gene Therapy in Oncology Product Overview
9.12.3 Johnson and Johnson Gene Therapy in Oncology Product Market Performance
9.12.4 Johnson and Johnson Business Overview
9.12.5 Johnson and Johnson Recent Developments
9.13 Marsala Biotech
9.13.1 Marsala Biotech Gene Therapy in Oncology Basic Information
9.13.2 Marsala Biotech Gene Therapy in Oncology Product Overview
9.13.3 Marsala Biotech Gene Therapy in Oncology Product Market Performance
9.13.4 Marsala Biotech Business Overview
9.13.5 Marsala Biotech Recent Developments
9.14 Merck
9.14.1 Merck Gene Therapy in Oncology Basic Information
9.14.2 Merck Gene Therapy in Oncology Product Overview
9.14.3 Merck Gene Therapy in Oncology Product Market Performance
9.14.4 Merck Business Overview
9.14.5 Merck Recent Developments
9.15 Mologen AG
9.15.1 Mologen AG Gene Therapy in Oncology Basic Information
9.15.2 Mologen AG Gene Therapy in Oncology Product Overview
9.15.3 Mologen AG Gene Therapy in Oncology Product Market Performance
9.15.4 Mologen AG Business Overview
9.15.5 Mologen AG Recent Developments
9.16 Oncolytics Biotech
9.16.1 Oncolytics Biotech Gene Therapy in Oncology Basic Information
9.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Overview
9.16.3 Oncolytics Biotech Gene Therapy in Oncology Product Market Performance
9.16.4 Oncolytics Biotech Business Overview
9.16.5 Oncolytics Biotech Recent Developments
9.17 Oncosec
9.17.1 Oncosec Gene Therapy in Oncology Basic Information
9.17.2 Oncosec Gene Therapy in Oncology Product Overview
9.17.3 Oncosec Gene Therapy in Oncology Product Market Performance
9.17.4 Oncosec Business Overview
9.17.5 Oncosec Recent Developments
9.18 Oncotelic
9.18.1 Oncotelic Gene Therapy in Oncology Basic Information
9.18.2 Oncotelic Gene Therapy in Oncology Product Overview
9.18.3 Oncotelic Gene Therapy in Oncology Product Market Performance
9.18.4 Oncotelic Business Overview
9.18.5 Oncotelic Recent Developments
9.19 Shenzhen SiBiono GeneTech
9.19.1 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Basic Information
9.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Overview
9.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Market Performance
9.19.4 Shenzhen SiBiono GeneTech Business Overview
9.19.5 Shenzhen SiBiono GeneTech Recent Developments
9.20 Sillajen Biotherapeutics
9.20.1 Sillajen Biotherapeutics Gene Therapy in Oncology Basic Information
9.20.2 Sillajen Biotherapeutics Gene Therapy in Oncology Product Overview
9.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Product Market Performance
9.20.4 Sillajen Biotherapeutics Business Overview
9.20.5 Sillajen Biotherapeutics Recent Developments
9.21 Tocagen
9.21.1 Tocagen Gene Therapy in Oncology Basic Information
9.21.2 Tocagen Gene Therapy in Oncology Product Overview
9.21.3 Tocagen Gene Therapy in Oncology Product Market Performance
9.21.4 Tocagen Business Overview
9.21.5 Tocagen Recent Developments
9.22 UniQure
9.22.1 UniQure Gene Therapy in Oncology Basic Information
9.22.2 UniQure Gene Therapy in Oncology Product Overview
9.22.3 UniQure Gene Therapy in Oncology Product Market Performance
9.22.4 UniQure Business Overview
9.22.5 UniQure Recent Developments
9.23 Ziopharm Oncology
9.23.1 Ziopharm Oncology Gene Therapy in Oncology Basic Information
9.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Overview
9.23.3 Ziopharm Oncology Gene Therapy in Oncology Product Market Performance
9.23.4 Ziopharm Oncology Business Overview
9.23.5 Ziopharm Oncology Recent Developments
10 Gene Therapy in Oncology Market Forecast by Region
10.1 Global Gene Therapy in Oncology Market Size Forecast
10.2 Global Gene Therapy in Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy in Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy in Oncology Market Size Forecast by Region
10.2.4 South America Gene Therapy in Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy in Oncology by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy in Oncology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy in Oncology by Type (2025-2030)
11.1.2 Global Gene Therapy in Oncology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy in Oncology by Type (2025-2030)
11.2 Global Gene Therapy in Oncology Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy in Oncology Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy in Oncology Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy in Oncology Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy in Oncology Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gene Therapy in Oncology Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene Therapy in Oncology Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene Therapy in Oncology Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2022)
Table 10. Global Market Gene Therapy in Oncology Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene Therapy in Oncology Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy in Oncology Product Type
Table 13. Global Gene Therapy in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy in Oncology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy in Oncology Market Challenges
Table 22. Global Gene Therapy in Oncology Sales by Type (K Units)
Table 23. Global Gene Therapy in Oncology Market Size by Type (M USD)
Table 24. Global Gene Therapy in Oncology Sales (K Units) by Type (2019-2024)
Table 25. Global Gene Therapy in Oncology Sales Market Share by Type (2019-2024)
Table 26. Global Gene Therapy in Oncology Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene Therapy in Oncology Market Size Share by Type (2019-2024)
Table 28. Global Gene Therapy in Oncology Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gene Therapy in Oncology Sales (K Units) by Application
Table 30. Global Gene Therapy in Oncology Market Size by Application
Table 31. Global Gene Therapy in Oncology Sales by Application (2019-2024) & (K Units)
Table 32. Global Gene Therapy in Oncology Sales Market Share by Application (2019-2024)
Table 33. Global Gene Therapy in Oncology Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene Therapy in Oncology Market Share by Application (2019-2024)
Table 35. Global Gene Therapy in Oncology Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene Therapy in Oncology Sales by Region (2019-2024) & (K Units)
Table 37. Global Gene Therapy in Oncology Sales Market Share by Region (2019-2024)
Table 38. North America Gene Therapy in Oncology Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gene Therapy in Oncology Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gene Therapy in Oncology Sales by Region (2019-2024) & (K Units)
Table 41. South America Gene Therapy in Oncology Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gene Therapy in Oncology Sales by Region (2019-2024) & (K Units)
Table 43. Bristol-Myers Squibb Gene Therapy in Oncology Basic Information
Table 44. Bristol-Myers Squibb Gene Therapy in Oncology Product Overview
Table 45. Bristol-Myers Squibb Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Gene Therapy in Oncology SWOT Analysis
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. Cold Genesys Gene Therapy in Oncology Basic Information
Table 50. Cold Genesys Gene Therapy in Oncology Product Overview
Table 51. Cold Genesys Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Cold Genesys Business Overview
Table 53. Cold Genesys Gene Therapy in Oncology SWOT Analysis
Table 54. Cold Genesys Recent Developments
Table 55. Advantagene Gene Therapy in Oncology Basic Information
Table 56. Advantagene Gene Therapy in Oncology Product Overview
Table 57. Advantagene Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Advantagene Gene Therapy in Oncology SWOT Analysis
Table 59. Advantagene Business Overview
Table 60. Advantagene Recent Developments
Table 61. Amgen Gene Therapy in Oncology Basic Information
Table 62. Amgen Gene Therapy in Oncology Product Overview
Table 63. Amgen Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. AstraZeneca Gene Therapy in Oncology Basic Information
Table 67. AstraZeneca Gene Therapy in Oncology Product Overview
Table 68. AstraZeneca Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Bio-Path Holdings Gene Therapy in Oncology Basic Information
Table 72. Bio-Path Holdings Gene Therapy in Oncology Product Overview
Table 73. Bio-Path Holdings Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Path Holdings Business Overview
Table 75. Bio-Path Holdings Recent Developments
Table 76. CRISPR Therapeutics Gene Therapy in Oncology Basic Information
Table 77. CRISPR Therapeutics Gene Therapy in Oncology Product Overview
Table 78. CRISPR Therapeutics Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. CRISPR Therapeutics Business Overview
Table 80. CRISPR Therapeutics Recent Developments
Table 81. Editas Medicine Gene Therapy in Oncology Basic Information
Table 82. Editas Medicine Gene Therapy in Oncology Product Overview
Table 83. Editas Medicine Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Editas Medicine Business Overview
Table 85. Editas Medicine Recent Developments
Table 86. Geron Corp Gene Therapy in Oncology Basic Information
Table 87. Geron Corp Gene Therapy in Oncology Product Overview
Table 88. Geron Corp Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Geron Corp Business Overview
Table 90. Geron Corp Recent Developments
Table 91. Idera Pharmaceuticals Gene Therapy in Oncology Basic Information
Table 92. Idera Pharmaceuticals Gene Therapy in Oncology Product Overview
Table 93. Idera Pharmaceuticals Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Idera Pharmaceuticals Business Overview
Table 95. Idera Pharmaceuticals Recent Developments
Table 96. Intellia Therapeutics Gene Therapy in Oncology Basic Information
Table 97. Intellia Therapeutics Gene Therapy in Oncology Product Overview
Table 98. Intellia Therapeutics Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Intellia Therapeutics Business Overview
Table 100. Intellia Therapeutics Recent Developments
Table 101. Johnson and Johnson Gene Therapy in Oncology Basic Information
Table 102. Johnson and Johnson Gene Therapy in Oncology Product Overview
Table 103. Johnson and Johnson Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Johnson and Johnson Business Overview
Table 105. Johnson and Johnson Recent Developments
Table 106. Marsala Biotech Gene Therapy in Oncology Basic Information
Table 107. Marsala Biotech Gene Therapy in Oncology Product Overview
Table 108. Marsala Biotech Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Marsala Biotech Business Overview
Table 110. Marsala Biotech Recent Developments
Table 111. Merck Gene Therapy in Oncology Basic Information
Table 112. Merck Gene Therapy in Oncology Product Overview
Table 113. Merck Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Merck Business Overview
Table 115. Merck Recent Developments
Table 116. Mologen AG Gene Therapy in Oncology Basic Information
Table 117. Mologen AG Gene Therapy in Oncology Product Overview
Table 118. Mologen AG Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Mologen AG Business Overview
Table 120. Mologen AG Recent Developments
Table 121. Oncolytics Biotech Gene Therapy in Oncology Basic Information
Table 122. Oncolytics Biotech Gene Therapy in Oncology Product Overview
Table 123. Oncolytics Biotech Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Oncolytics Biotech Business Overview
Table 125. Oncolytics Biotech Recent Developments
Table 126. Oncosec Gene Therapy in Oncology Basic Information
Table 127. Oncosec Gene Therapy in Oncology Product Overview
Table 128. Oncosec Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Oncosec Business Overview
Table 130. Oncosec Recent Developments
Table 131. Oncotelic Gene Therapy in Oncology Basic Information
Table 132. Oncotelic Gene Therapy in Oncology Product Overview
Table 133. Oncotelic Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Oncotelic Business Overview
Table 135. Oncotelic Recent Developments
Table 136. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Basic Information
Table 137. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Overview
Table 138. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Shenzhen SiBiono GeneTech Business Overview
Table 140. Shenzhen SiBiono GeneTech Recent Developments
Table 141. Sillajen Biotherapeutics Gene Therapy in Oncology Basic Information
Table 142. Sillajen Biotherapeutics Gene Therapy in Oncology Product Overview
Table 143. Sillajen Biotherapeutics Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Sillajen Biotherapeutics Business Overview
Table 145. Sillajen Biotherapeutics Recent Developments
Table 146. Tocagen Gene Therapy in Oncology Basic Information
Table 147. Tocagen Gene Therapy in Oncology Product Overview
Table 148. Tocagen Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Tocagen Business Overview
Table 150. Tocagen Recent Developments
Table 151. UniQure Gene Therapy in Oncology Basic Information
Table 152. UniQure Gene Therapy in Oncology Product Overview
Table 153. UniQure Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. UniQure Business Overview
Table 155. UniQure Recent Developments
Table 156. Ziopharm Oncology Gene Therapy in Oncology Basic Information
Table 157. Ziopharm Oncology Gene Therapy in Oncology Product Overview
Table 158. Ziopharm Oncology Gene Therapy in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Ziopharm Oncology Business Overview
Table 160. Ziopharm Oncology Recent Developments
Table 161. Global Gene Therapy in Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Gene Therapy in Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Gene Therapy in Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Gene Therapy in Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Gene Therapy in Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Gene Therapy in Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Gene Therapy in Oncology Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Gene Therapy in Oncology Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Gene Therapy in Oncology Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Gene Therapy in Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Gene Therapy in Oncology Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Gene Therapy in Oncology Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Gene Therapy in Oncology Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Gene Therapy in Oncology Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Gene Therapy in Oncology Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Gene Therapy in Oncology Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Gene Therapy in Oncology Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gene Therapy in Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy in Oncology Market Size (M USD), 2019-2030
Figure 5. Global Gene Therapy in Oncology Market Size (M USD) (2019-2030)
Figure 6. Global Gene Therapy in Oncology Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy in Oncology Market Size by Country (M USD)
Figure 11. Gene Therapy in Oncology Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy in Oncology Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy in Oncology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy in Oncology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy in Oncology Market Share by Type
Figure 18. Sales Market Share of Gene Therapy in Oncology by Type (2019-2024)
Figure 19. Sales Market Share of Gene Therapy in Oncology by Type in 2023
Figure 20. Market Size Share of Gene Therapy in Oncology by Type (2019-2024)
Figure 21. Market Size Market Share of Gene Therapy in Oncology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy in Oncology Market Share by Application
Figure 24. Global Gene Therapy in Oncology Sales Market Share by Application (2019-2024)
Figure 25. Global Gene Therapy in Oncology Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy in Oncology Market Share by Application (2019-2024)
Figure 27. Global Gene Therapy in Oncology Market Share by Application in 2023
Figure 28. Global Gene Therapy in Oncology Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene Therapy in Oncology Sales Market Share by Region (2019-2024)
Figure 30. North America Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gene Therapy in Oncology Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gene Therapy in Oncology Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gene Therapy in Oncology Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gene Therapy in Oncology Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gene Therapy in Oncology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gene Therapy in Oncology Sales Market Share by Region in 2023
Figure 44. China Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gene Therapy in Oncology Sales and Growth Rate (K Units)
Figure 50. South America Gene Therapy in Oncology Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gene Therapy in Oncology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gene Therapy in Oncology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gene Therapy in Oncology Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gene Therapy in Oncology Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gene Therapy in Oncology Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene Therapy in Oncology Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene Therapy in Oncology Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene Therapy in Oncology Sales Forecast by Application (2025-2030)
Figure 66. Global Gene Therapy in Oncology Market Share Forecast by Application (2025-2030)
